/ Published in 2009, Publication

Measurement and predictors of adherence in a trial of HSV suppressive therapy in Tanzania

Measurement and predictors of adherence in a trial of HSV suppressive therapy in Tanzania.

Watson-Jones D, Baisley K, Rusizoka M, Mugeye K, Weiss H, Changalucha J, Clayton T, Hambleton I, Ross DA, Hayes R.
Contemporary Clinical Trials. 2009; 30: 504-512.
PMID: 19665587
Related citation

What you can read next

Use of acyclovir for suppression of human immunodeficiency virus infection is not associated with genotypic evidence of herpes simplex virus type 2 resistance to acyclovir: analysis of specimens from three phase III trials.
Microbicides Development Programme. Are women who work in bars, guesthouses and similar facilities a suitable study population for vaginal microbicide trials in Africa?
Nocturnal dipping of heart rate and blood pressure in people with HIV in Tanzania